Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Parathyroid disorder
ADR ID BADD_A03302
ADR Hierarchy
05      Endocrine disorders
05.04      Parathyroid gland disorders
05.04.03      Parathyroid disorders NEC
05.04.03.001      Parathyroid disorder
Description Pathological processes of the PARATHYROID GLANDS. They usually manifest as hypersecretion or hyposecretion of PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. [MeSH]
MedDRA Code 10033942
MeSH ID D010279
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Disorder parathyroid | Disorders of parathyroid gland | Dysfunction parathyroid | Other specified disorders of parathyroid gland | Parathyoid disorder | Parathyroid disorder | Parathyroid disorder NOS | Parathyroid dysfunctiuon | Parathyroidal disturbance | Unspecified disorder of parathyroid gland | Parathyroid Diseases | Disease, Parathyroid | Diseases, Parathyroid | Parathyroid Disease | Parathyroid Disorders | Disorder, Parathyroid | Disorders, Parathyroid | Parathyroid Disorder
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00041Adalimumab--
BADD_D00064Alemtuzumab--
BADD_D00066Alendronic acid0.000044%
BADD_D00156Apremilast0.000241%
BADD_D00286Bosutinib0.000112%
BADD_D00364Carboplatin0.000112%
BADD_D01117Ibandronic acid--
BADD_D01124Icodextrin--
BADD_D01271Levocarnitine--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid--
BADD_D01676Paricalcitol0.003924%
BADD_D01835Pregabalin--
BADD_D01942Riluzole--
BADD_D01948Riociguat--
BADD_D02028Sirolimus--
BADD_D02105Tacrolimus--
BADD_D02236Tofacitinib0.000241%
BADD_D02392Zoledronic acid--
BADD_D02434Cinacalcet0.008014%
The 1th Page    1    Total 1 Pages
ADReCS-Target
ADR Term Drug Name Target